
December 2002 From Porter Novelli Hemophilia therapy update: New information on investigational Factor VIII therapy development WEBCAST INVITATIONHemophilia Therapy Update: New Information on Investigational Factor VIII Therapy Development Monday, December 9, 2002 12:30 -- 1:30 EST Loews Philadelphia Hotel, Commonwealth Hall A AGENDA Understanding Treatment Choices -- A Father's Perspective Joe Caronna, Vice President, New Jersey Hemophilia Association, and Father of Patient with Hemophilia A The Current Hemophilia Treatment Landscape W. Keith Hoots, M.D., Medical Director, Gulf States Hemophilia and Thrombophilia Center, Houston, Texas Phase II-III Antihemophilic Factor (Recombinant), Plasma/Albumin Free Method (rAHF-PFM) Clinical Trial Data Peter Collins, M.D., M.R.C.P., Director, Arthur Bloom Haemophilia Centre, University Hospital of Wales, Cardiff, Wales New Developments in Recombinant Factor VIII Technology Edward D. Gomperts, M.D., Global Vice President, Medical Affairs, Baxter BioScience Moderator: Edward D. Gomperts, M.D. To register for the live webcast, please enter the newsroom of Baxter.com (http://www.baxter.com) and click on the "Hemophilia Therapy Update Webcast" button. To R.SV.P. for the briefing or to receive additional information, please contact: Nicole Christopher at 212-601-8279 or [email protected] Sherry Marks at 212-601-8385 or [email protected] |